4-(2-aminobenzoyl)benzonitrile | 133776-50-8

• 分子结构分类: 有机化合物 - 苯类化合物 - 苯和取代衍生物
• 英文名称: 4-(2-aminobenzoyl)benzonitrile
• CAS: 133776-50-8
• 化学式: C₁₄H₁₀N₂O
• 分子量: 222.246
• InChiKey: SYNRPDIBCNBKGP-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3
• 重原子数：
  17
• 可旋转键数：
  2
• 环数：
  2.0
• sp3杂化的碳原子比例：
  0.0
• 拓扑面积：
  66.9
• 氢给体数：
  1
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  4-(2-aminobenzoyl)benzonitrile 在 potassium hydroxide 、 肼 作用下， 以 四氢呋喃 、 乙醇 、 水 、 N,N-二甲基甲酰胺 为溶剂， 反应 1.54h， 生成 4-(5-(4-chlorophenyl)-3-(4-(4-cyanophenyl)-2-oxo-1,2-dihydroquinolin-3-yl)-4,5-dihydro-1H-pyrazol-1-yl)-4-oxobutanoic acid
  参考文献：
  名称：

  Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists

  摘要：

  Here we describe the synthesis and structure-activity relationship for a class of pyrazoline-containing dihydroquinolone negative allosteric modulators of the NMDA receptor that show strong subunit selectivity for GluN2C- and GluN2D-containing receptors over GluN2A- and GluN2B-containing receptors. Several members of this class inhibit NMDA receptor responses in the nanomolar range and are more than 50-fold selective over GluN1/GluN2A and GluN1/GluN2B NMDA receptors, as well as AMPA, kainate, GABA, glycine, nicotinic, serotonin, and purinergic receptors. Analysis of the purified enantiomers of one of the more potent and selective compounds shows that the S-enantiomer is both more potent and more selective than the R-enantiomer. The S-enantiomer had an IC50 of 0.17-0.22 mu M at GluN2D- and GluN2C-containing receptors, respectively, and showed over 70-fold selectivity over other NMDA receptor subunits. The subunit selectivity of this class of compounds should be useful in defining the role of GluN2C- and GluN2D-containing receptors in specific brain circuits in both physiological and pathophysiological conditions.

  DOI：

  10.1021/jm400652r
• 作为产物：
  描述：

  靛红酸酐 在 正丁基锂 、 三乙胺 作用下， 以 四氢呋喃 、 乙醇 、 正己烷 为溶剂， 反应 2.17h， 生成 4-(2-aminobenzoyl)benzonitrile
  参考文献：
  名称：

  Structure–Activity Relationships and Pharmacophore Model of a Noncompetitive Pyrazoline Containing Class of GluN2C/GluN2D Selective Antagonists

  摘要：

  Here we describe the synthesis and structure-activity relationship for a class of pyrazoline-containing dihydroquinolone negative allosteric modulators of the NMDA receptor that show strong subunit selectivity for GluN2C- and GluN2D-containing receptors over GluN2A- and GluN2B-containing receptors. Several members of this class inhibit NMDA receptor responses in the nanomolar range and are more than 50-fold selective over GluN1/GluN2A and GluN1/GluN2B NMDA receptors, as well as AMPA, kainate, GABA, glycine, nicotinic, serotonin, and purinergic receptors. Analysis of the purified enantiomers of one of the more potent and selective compounds shows that the S-enantiomer is both more potent and more selective than the R-enantiomer. The S-enantiomer had an IC50 of 0.17-0.22 mu M at GluN2D- and GluN2C-containing receptors, respectively, and showed over 70-fold selectivity over other NMDA receptor subunits. The subunit selectivity of this class of compounds should be useful in defining the role of GluN2C- and GluN2D-containing receptors in specific brain circuits in both physiological and pathophysiological conditions.

  DOI：

  10.1021/jm400652r

文献信息

• Deoxygenative Arylation of Carboxylic Acids by Aryl Migration
  作者：Rehanguli Ruzi、Junyang Ma、Xiang‐Ai Yuan、Wenliang Wang、Shanshan Wang、Muliang Zhang、Jie Dai、Jin Xie、Chengjian Zhu

  DOI：10.1002/chem.201903816

  日期：2019.10

  phosphoranyl radical chemistry allows for precise cleavage of a stronger C-O bond and formation of a weaker C-C bond by 1,5-aryl migration under mild reaction conditions. This new protocol is independent of substrate redox-potential, electronic, and substituent effects. It affords a general and promising access to 60 examples of synthetically versatile o-amino and o-hydroxy diaryl ketones under redox-neutral

  已经实现了前所未有的芳香族羧酸脱氧芳基化反应，从而可以构建增强的不对称二芳基酮库。协同的光氧化还原催化作用和磷烷基自由基化学反应可在温和的反应条件下，通过1,5-芳基迁移，精确裂解更强的CO键并形成较弱的CC键。此新协议独立于底物氧化还原电势，电子和取代基效应。在氧化还原中性条件下，它提供了60种合成通用的邻氨基和邻羟基二芳基酮的通用且有希望的途径。此外，以令人满意的产率，它也为全合成喹诺酮生物碱，（±）-yaequinolone A2和viridicatin衍生物提供了一条简洁的途径。
• 一种由芳香羧酸合成邻氨基芳香酮的方法
  申请人：南京大学

  公开号：CN109824530B

  公开（公告）日：2021-09-28

  一种由芳香羧酸制备邻氨基芳香酮的方法，它是以2‑芳基磺酰胺基芳香羧酸为原料，三苯基膦作为脱氧剂，在蓝光灯照射下，在1,4‑二氧六环溶液中，氩气气氛下，在磷酸氢二钾存在下，以[Ir(dF(CF3)ppy)2(dtbbpy)]PF6为光催化剂，得到邻氨基芳香酮化合物；所述的光催化剂[Ir(dF(CF3)ppy)2(dtbbpy)]PF6如下结构：。
• An Atom-Economical Method To Prepare Enantiopure Benzodiazepines with <i>N</i>-Carboxyanhydrides
  作者：Patrick S. Fier、Aaron M. Whittaker

  DOI：10.1021/acs.orglett.7b00417

  日期：2017.3.17

  development of a rapid, one-pot synthesis of diazepinones with simple reagents is described. N-Carboxyanhydrides (NCAs) are employed as amino acid building blocks that react with o-ketoanilines sequentially as electrophiles and nucleophiles to form diazepinones with water and carbon dioxide as byproducts. Notably, these reactions enable the coupling of stereodefined amino acid derived NCAs without racemization

  描述了用简单的试剂快速，一锅法合成二氮杂酮的进展。N-羧基氰化物（NCA）被用作氨基酸构建基，它们与邻-酮苯胺依次作为亲电子试剂和亲核试剂反应，以水和二氧化碳为副产物形成二氮杂蒽酮。值得注意的是，这些反应能够偶联立体定义的氨基酸衍生的NCA而无需消旋。通过向溴结构域和末端外（BET）溴结构域抑制剂的关键中间体的改进合成证明了该方法。
• Transition-Metal-Free Synthesis of Acridones via Base-Mediated Intramolecular Oxidative C−H Amination
  作者：Wen-Tao Wei、Jian-Fei Sheng、Hui Miao、Xiang Luo、Xian-Heng Song、Ming Yan、Yong Zou

  DOI：10.1002/adsc.201701579

  日期：2018.6.5

  was achieved in the presence of potassium tert‐butoxide and dimethyl sulfoxide. A series of functionalized acridones were prepared in moderate to excellent yields in a mild, efficient, and transition‐metal‐free manner.

  在叔丁醇钾和二甲基亚砜的存在下，实现了2-氨基二苯甲酮的分子内氧化CH氨基化反应。以温和，有效和无过渡金属的方式，以中等至极好的收率制备了一系列功能化的cri啶。
• Pyrimidine as PLK inhibitors
  申请人：Stadtmueller Heinz

  公开号：US20050261295A1

  公开（公告）日：2005-11-24

  The present invention comprises compounds of general formula (1) wherein A, X, Y, Z, R a , R b , R c , R 1 , R 2 and R 3 are defined as in claim 1, which are suitable for the treatment of diseases characterised by excessive or anomalous cell proliferation, and the use thereof for preparing a pharmaceutical composition with the above-mentioned properties.

  本发明涉及一般式（1）的化合物，其中A、X、Y、Z、Ra、Rb、Rc、R1、R2和R3如权利要求1所定义，适用于治疗由过度或异常细胞增殖所特征的疾病，并将其用于制备具有上述特性的制药组合物。